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Abstract:
About 43% of eukaryotic proteins contain intrinsically disordered regions (IDRs) of 40 residues
or longer. These proteins modulate key cellular functions such as transcription, translation, and
signal transduction. Despite their vital roles, little is known about the properties of large
disordered proteins due to the difficulties encountered studying them. Solution nuclear
magnetic resonance (NMR) spectroscopy is a unique tool allowing for their analysis but
traditionally requires uniform protein labeling with 15N and 13C isotopes resulting in convoluted
spectra which obscure any meaningful information on their structures and interactions. To
remedy this issue, we aim at developing a procedure to segmentally label large IDR-containing
proteins by synthesizing them as separate fragments before ligating them together using
sortase enzymes. This method would allow for the recording of 15N/13C-HSQC experiments of
smaller IDR/IDP segments at a time, avoiding spectral overlap while retaining the proteins’
native biochemical environment. We focus our work on cytoskeletal regulators, dematin (Homo
sapiens) and villin 4 (Arabidopsis thaliana) each comprising a large IDR. Both dematin and villin
4 bind and control the bundling of filamentous actin (F-actin) but their mechanism of action
remains unclear. We plan to use segmental labeling (SL) to gain insight into their respective
properties which would help advance both the medical (dematin) and agricultural (villin 4)
fields.
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Chapter I: Introduction
1.1 Intrinsically Disordered Regions/Proteins (IDRs/IDPs):
Structural biologists long considered a tertiary structure indispensable for proteins to be able to
perform their various functions1. However, numerous polypeptides studied since this model
was established in the 1960s have come to challenge this notion. Intrinsically disordered
regions/proteins (IDRs/IDPs) are characterized by the absence of a stable defined threedimensional structure. In fact, they often adopt a variety of conformational states which are in
dynamic equilibrium with one another under physiological conditions1,2. Moreover, recent
estimates report that close to 43% of proteins within eukaryotes contain IDRs larger than 40
residues in length3. Their flexible nature, capacity to bind several partners simultaneously with
great specificity yet low affinity, along with their tendency to undergo post-translational
modifications allow IDRs/IDPs to act as mediators in a multitude of signaling pathways through
allosteric changes4. These same features make IDRs/IDPs accessory proteins which aid in the
organization of macromolecule complexes such as chromatin, the ribosome, and the
cytoskeleton4.
In addition to their roles as central protein hubs, IDRs/IDPs make up a large portion of the
mRNA splicing and post-translational silencing machineries4,5. Finally, unstructured proteins are
known to promote phase separation which leads to the formation of membrane-less organelles
in the cytoplasm6, thus contributing to the necessary compartmentalization of biochemical
processes in the cell.

Because of their vital cellular functions, mutations in the amino acid sequence of IDRs which
alter their level of disorder are associated with several cancers and neurodegenerative
disorders such as such as Alzheimer's, Parkinson's, and Huntington's diseases1,7,8.
1.2 Challenges of Studying IDRs/IDPs:
In spite of their biological significance, IDRs/IDPs remain a mysterious class of proteins. IDRs’
dynamic nature exposes the limitation of many characterization methods such as X-ray
crystallography1,9, able to only capture a single conformation at a time, an incomplete and
often misleading picture as it is not representative of the various structures IDRs adopt in vivo,
not to mention IDR’s inherent inability to form crystals. Unlike X-ray crystallography, solution
NMR spectroscopy is a powerful tool able to characterize the various forms and interactions of
IDRs9. However, some limitations do persist: long recording time, especially for 3D
heteronuclear NMR which is problematic because IDRs are prone to degradation via proteolytic
cleavage10.
NMR experiments also require protein expression in minimal media which often results in low
yield9. If a purification tag is included, it may also interfere with function of these disordered
segments. Therefore, careful consideration should be given to the construct design and
purification scheme.
Although the manipulation of experimental parameters may help mitigate some of the above
inconveniences, one major hurdle continues to pose a serious challenge to the acquisition of
meaningful NMR data on IDRs, spectral overlap9,11. Because the entire IDR/IDP is typically
isotopically labeled, the resulting spectrum is plagued with significant signal overlap, impeding
2

the peak assignment and thus structure characterization process. One way to circumvent the
problem would be to label small segments within the IDR at a time, leaving the rest of the
protein unlabeled, allowing for a considerable decrease in the number of peaks that would
appear on the spectrum while preserving the amino acid context of studied segment. To
produce a segmentally labeled construct, the IDR/IDP needs to be synthesized in separate
fragments (Figure 1.2.1). The fragments would then be covalently linked through a variety of
mechanisms. Segmental labeling was successfully accomplished to analyze the properties of
folded proteins12. To the best of our knowledge, segmental labeling (SL) has yet to be applied to
the characterization of IDRs/IDPs.

Figure 1.2.1. Segmental labelling (SL) of protein segments (A, B, or C)
according to experimental needs. Labeled fragments are indicated in
yellow, blue shows unlabeled protein portions.
Traditionally, SL is achieved through a combination of native chemical ligation (NCL)13,
expressed protein ligation (EPL)13,14, or protein trans-splicing (PTS) mechanisms12–14. These
established strategies possess a number of limitations in terms of their design. For both NCL
and EPL, the presence of a N-terminal cysteine and a C-terminal thioester is critical to the
success of the ligation reaction. When introducing a cysteine to a wild-type sequence lacking it
to allow for the ligation to occur, the potential for unwanted disulfide interactions increases,
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leading to possible alteration of the protein structure and function 15,16. While desulfurization
may be a suitable solution to this problem, it will likely disturb the network of native disulfide
bonds, ultimately affecting protein shape and activity15–17. Finally, many purification steps
associated with the above methods result in significant losses in yield 17, emphasizing the need
for novel strategies to address these current hurdles. Thus, we propose sortase-mediated
ligation (SML) as an additional SL procedure. Our current work focuses on using SML to
segmentally label various IDRs/IDPs under investigation. As an eventual expansion to our
project, we plan to incorporate EPL to our synthesis scheme to allow for the isotopic labelling of
internal protein segments (Figure 1.3.2).
1.3 Sortase-Mediated Ligation (SML):
Sortase enzymes are transpeptidases found in bacterial cells18. They recognize and covalently
attach surface proteins onto the peptidoglycan layer in gram-positive bacteria, thus playing a
key role in the virulence of these pathogens. Depending on the organism from which they are
derived, sortase variants perform different roles and recognize different sorting signals19,20.
Sortase A, isolated from Staphylococcus aureus, targets the LPXTG sequence motif and cleaves
between the threonine (T) and glycine (G) residues19 (Figure 1.3.1). It proceeds to catalyze the
reversible ligation reaction between the C-terminal end of this motif (LPXT) and an N-terminal
glycine nucleophile present at the surface of the bacterial cell wall. Many known sortase
proteins have been genetically engineered to enhance their affinity to particular substrates as
well as their specificity and ligation efficiency20–22. In this thesis, we utilize wild-type sortase A
(WT-srtA) and the hepta-mutant variant (7m-srtA) which compared to WT-srtA, does not
depend on calcium for its activity and has been shown to have greater catalytic activity21. If the
4

IDR/IDP of interest contains a sortase recognition sequence either natively or through the
introduction of conservative/minimally-disruptive mutations, SML could be utilized to
synthesize a segmentally labeled sample suitable for NMR studies. Additionally, when
combined with other ligation methods, such as EPL, it would allow for greater flexibility in
terms of which fragment gets labeled (Figure 1.3.2).

Figure 1.3.1. Synthesis of a segmentally isotopically labeled protein via SML using sortase A
(Staphylococcus aureus).

5

Figure 1.3.2. Tentative synthesis scheme to segmentally label a generic protein using
expressed protein ligation (EPL) in combination with sortase-mediated ligation (SML). EPL
requires an N-terminal cysteine and a C-terminal thioester at the ligation site. A cleavage
step following the EPL step allows for the exposure of an N-terminal glycine nucleophile
necessary for SML. Sortase enzymes used in our lab cleave between the threonine and
glycine within the LPXTG motif, allowing for the N-terminal glycine generated in step 2
required for SML to occur.

1.4 The Cytoskeleton:
In eukaryotic cells, the cytoskeleton is the structure responsible for maintaining cell shape and
internal organization23. It controls a multitude of important cellular processes from motility and
adhesion to cytokinesis and cell polarity. It comprises microtubules, microfilaments, and
intermediate filaments24. Microfilaments are composed of two interweaved strands of globular
actin (G-actin) monomers23. Because of the way G-actin proteins are oriented, the resulting
actin filaments (F-actin) are endowed with polarity and distinguishable plus (+) and minus (-)
ends, a feature which determines the direction of myosin movement in the cell. Such an
interaction between F-actin and myosin provides the molecular basis for muscle contraction25.
6

Actin filaments are highly dynamic, constantly assembling and disassembling depending on the
concentration of free G-actin proteins23. Upon aggregation of a few G-actin monomers, the
spontaneous elongation of F-actin is initiated at both ends of the polymer. G-actin subunits also
bind and hydrolyze ATP upon their association such that the G-actin-ADP complex disassociates
more easily than the G-actin-ATP pair, resulting in treadmilling. This phenomenon refers to the
difference in the polymerization rate between the two extremities as the plus end grows faster
than the minus end.
In the cell, actin filaments are either arranged into bundles or networks23 (Figure 1.4.1). In
bundles, F-actin is crosslinked in a parallel pattern whereas in networks, it is loosely crosslinked
in a perpendicular fashion, forming a gel-like meshwork. The formation of these structures is
modulated by actin binding proteins (ABP) which assemble F-actin into these different
configurations in response to changing environmental stimuli. In fact, ABPs control nearly all
aspects of microfilament formation. Examples of actin-binding proteins include the villin family
and its homologs.

7

Figure 1.4.123. Schematic representation of F-actin organization in eukaryotic cells. A)
Parallel F-actin bundles held by various ABPs. Typically, a space of 14 nm separates
microfilaments from each other23. B) F-actin cross-linked into perpendicular arrangements
through the catalytic activity other ABPs.
1.5 Microfilament Regulators:
There are numerous proteins that function as F-actin regulators. This section provides a general
introduction to a few ABPs relevant to the content presented in this document: gelsolin,
supervillin, villin, and dematin.
1.5.1 Gelsolin:
Gelsolin regulates F-actin assembly and disassembly through its ability to sever and cap
filamentous actin26. In animals lacking the gelsolin gene, significant disruptions in wound
healing and clotting mechanisms were observed, further asserting the vital role this protein
plays in many cellular processes. Gelsolin is composed of six repeat domains, S1-S6 (Figure
1.5.1). The C-terminal portion of gelsolin binds F-actin when calcium levels exceed 1 µM and
acts as a modulator to the N-terminal moiety capable of capping and severing F-actin,
irrespective of calcium concentrations. X-ray crystallography studies revealed that in the
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absence of calcium the S4 and S6 segments combine into a single beta sheet but upon calcium
introduction, the secondary structure disappears as S4 detaches from S6 and binds to S5 and
actin. These findings support the role calcium plays in inducing the conformational changes
necessary to trigger gelsolin’s capping and severing functions. Interestingly, through initiating Factin depolymerization, gelsolin may be a major a player in F-actin nucleation as its activity
results in an increase of F-actin minus ends and free-floating actin monomers.

Figure 1.5.1. Comparison of some actin-binding proteins belonging to the villin family. Villin,
gelsolin, and supervillin all possess the characteristic 6 tandem gelsolin domains while
dematin lacks them. With the exception of gelsolin, all villin-like proteins contain a folded
headpiece domain capable of binding actin. In supervillin however, F-actin binding sites are
located within its exceptionally-large 830-residue IDR.

1.5.2 Villin:
The villin class belongs to a group of actin-binding proteins known as the villin/gelsolin/fragmin
family27. These proteins share significant sequence homology in terms of their 6 successive
gelsolin domains, S1-S6 (Figure 1.5.1). Unlike gelsolin, villin proteins are distinguishable by the
presence of a folded headpiece domain on their C-terminal end, also found in supervillin and
dematin. The headpiece is attached to the signature gelsolin core via an unstructured segment

9

(IDR). This folded domain allows villin to assemble actin filaments into bundles in a calciumsensitive manner. In vertebrates, villin is found in microvilli of epithelial cells both in the small
intestine and kidneys28 . In plants, however, different villin isoforms are distributed throughout
various tissues and contribute to maintaining larger structures than their vertebrate
counterparts27,28. Despite having a similar role, plant villin proteins share little sequence
homology with their vertebrate equivalents in the IDR connecting their gelsolin core to their
headpiece domain. It is unclear how these differences affect their respective mode of
operation.
1.5.2a. Bovine Supervillin:
Supervillin, a member of the villin family, controls many aspects of cell motility, division,
adhesion, and communication23,29. In addition to possessing the six gelsolin domains (S1-S6)
and the characteristic villin headpiece, it is composed of a large N-terminal IDR of 830
residues29 (Figure 1.5.1). While it retains its capacity to bundle microfilaments, it does so
through its N-terminal segment because a change in sequence inhibits such activity at the Cterminal end, the typical F-actin bundling site for other villin proteins. Along with filamentous
actin, supervillin interacts with Myosin II and around 70 other signaling macromolecules.
Computational analysis combined with actin co-sedimentation assays established the presence
of three actin binding sites on the A1, A2, and A3 segments, as well as two myosin II sites within
the M portion of the IDR (Figure 1.5.2).
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Figure 1.5.229. Location of F-actin and myosin I binding sites on the 830-residue N-terminal
IDR of bovine supervillin. Segments containing F-actin binding sites (AB1, AB2, AB3) are
depicted in blue along with Myosin I binding sites (MB1, MB2), all are composed of basic
amino acids. Proposed actin-binding sites are highlighted with asterisks (*). Theoretical pI
values for relevant segments as well as the amino acid positions are indicated above and
below the IDR, respectively. Image reproduced based on Dr. Sergey Smirnov’s original figure.

Both Actin and myosin II are predicted to carry an overall negative charge at physiological pH
(Figure 1.5.3), given their respective pI values of 5.5 and 4.329. Contrastingly, bovine supervillin
remains positively charged under the same conditions. In fact, supervillin fragments shown to
bind actin were characterized by pI values of 9.8, 8.4, and 10.2 for AB1, AB2, AB3, respectively,
making them quite positively charged at neutral pH (Figure 1.5.2). This difference in charges
suggests an electrostatic interaction as the main mechanism through which supervillin binds Factin. Such a hypothesis is equally plausible in the context of Myosin II association. Indeed,
progressive increase of salt concentrations has been shown to lower supervillin’s affinity for
Myosin II, further supporting the electrostatic model.

11

Figure 1.5.329. Charge partioning on the surface of microfilaments at
physiological pH. Acidic residues are shown in red, basic amino acids
are represented in blue. Neutral residues are depicted in gray. Image
curtesy of Dr. Sergey Smirnov, WWU.

1.5.2b. Villin 4 (Arabidopsis thaliana):
Arabidopsis thaliana contains 5 villin variants expressed in a ubiquitous manner throughout the
plant27. Villin isoform 4 (AtV4) retains the gelsolin core and the characteristic C-terminal
headpiece domain linked together by a 190-residue IDR (Figure 1.5.4). AtV4 performs the same
functions attributed to the villin family but is especially important to the growth of plant root
hair. Plants lacking the villin 4 gene show a decrease in the formation of actin cables, leading to
significantly fewer and shorter root hairs. AtV4 binds actin filaments irrespective of the
presence of calcium. Its severing and bundling activity however does depend on calcium levels
in the cell. In normal physiological conditions (<10 μM Ca2+) AtV4 promotes the formation of
12

actin bundles27,28. On the other hand, when the levels of calcium increase to about 50-200 μM,
its severing function is favored, and the bundles found at higher Ca2+ concentration were
significantly shorter, suggesting that villin 4 regulates not only the formation but also the length
of actin bundles in response to stressful stimuli27.

Figure 1.5.4. Structure of villin 4 (Arabidopsis thaliana). Six gelsolin domains are shown as the
core which spans residues 1-720. The core is linked to the folded headpiece domain (residues
911-974) via a disordered region (721-910). This IDR is composed of a basic segment (blue,
residues 721-869 ) separated by a predicted PEST motif (~870-879) to the acidic portion (red,
residues ~880-911)
Analysis by Dr. Smirnov, from the Chemistry department at Western Washington University, of
the IDR sequence of villin 4 reveals a distinct charge partitioning. Indeed, the IDR N-terminal
portion is enriched in basic residues while its C-terminal segment has a preponderance of acidic
amino acids. These two fragments are separated by a predicted PEST motif which is recognized
by the cell as a cleavage signal (Figure 1.5.4). This same charge partioning is found in the large
830-residue N-terminal IDR of supervillin29, which was shown to contain Myosin II and F-actin
binding sites (Figure 1.5.2). In supervillin, as discussed in the above section, these interactions
were hypothesized to be driven by electrostatic forces. Because of the similarities in charge
separation between supervillin’s and villin 4’s respective IDRs, comparable intermolecular
forces may be responsible for villin 4’s capacity to bind F-actin.
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The first step in investigating this hypothesis would be to synthesize and purify the full-length
villin 4 linker then subject it to an actin pull-down assay. A difficult task which faces all the
hurdles associated with the production and analysis of large disordered protein segments
mentioned in section 1.2. The propensity of the villin 4 IDR to degradation is heightened by the
presence of a predicted PEST motif between its acidic and basic portions which makes it a
target for proteases inside the host bacterial cells where it is expressed30. Although in vitro
synthesis could be considered to solve this issue, it is time-consuming; methods such as solid
phase peptide synthesis (SPPS) are best suited to produce peptides less than 70 residues long31.
Furthermore, the frequent incidence of side reactions and multiple purification steps reduce
the desired product’s yield. An optimized procedure that may utilize SML biotechnology for the
synthesis and purification of the large villin 4 IDR is needed. Once produced, several studies can
be conducted to decipher how proteins such as villin 4 operate to modulate F-actin assembly,
relying on solution NMR spectroscopy and fluorescent microscopy, among other
instrumentation techniques.
Previous work our lab conducted on villin 4 (Arabidopsis thaliana) perfectly illustrates the great
capabilities of sortase within the context of NMR-driven structural characterization of IDPs. The
isotopically labeled acidic IDR portion in villin 4 was successfully ligated to an unlabeled villin 4
folded headpiece using sortase enzymology32. 15N-HSQC spectra were then recorded at various
temperatures (15 ℃, 25 ℃, and 45 ℃). Analysis of the spectra obtained indicated unequal
temperature sensitivity across the acidic IDR sequence. Due to the known temperature
dependence plants show during various stages of their growth processes, such observations
raise several questions on the role of AtV4 IDR in plant maturation. The data collected in these
14

experiments would have been difficult to interpret had the entire protein been labeled with 15N
isotopes due to the challenges outlined in section 1.2.
Surprisingly, the presence of the acidic stretch (EDEED) at the N-terminal end of LPXTG sortase
site significantly hindered the ligation efficiency. However, introduction of a glycine spacer
between the EDEED sequence and the sortase motif was sufficient to resolve the issue (Figure
1.5.5). This unexpected finding calls for further investigation into the effects of various types of
neighboring amino acid residues on SML efficiency, specifically in the context of real IDR
sequences, the focus of this thesis.
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Figure 1.5.532. Effect of N-terminal acidic residues on SML efficiency. A) SML
between the acidic IDR stretch in villin 4 (Arabidopsis thaliana) and a polyglycine N-terminal nucleophile using a hepta-mutant variant of sortase A. FH8
and His6 tags are included for purification and solubility enhancement (FH8)
purposes. B) SML reaction in A was conducted at room temperature for 4
hours and monitored via LC-ESI-MS. The reaction efficiency increases with the
insertion of glycine spacers between the LPXTG ligation site and the IDR acid
stretch EDEED. C) Mass spectrum of ligation product containing one glycine as
the spacer (13296 Da).

16

1.5.3 Dematin 2 (Homo sapiens):
Dematin (Homo sapiens) is an F-actin-binding and bundling protein originally identified in the
spectrin-actin junction of erythrocytes33. It is also present in human platelets (acting as a
calcium modulator) heart, brain, kidney, and lens tissue34. It is known to control cell adhesion
and motility in these various organs though the negative regulation of the Rho GTPase
activation pathway35. Dematin (isoform 2) is composed of a 315-residue N-terminal disordered
region and a folded C-terminal domain 68-residues long, homologous to the headpiece domain
found in the villin family35,36 (Figure 1.5.6). Dematin is regulated through the phosphorylation of
its headpiece domain at the Ser381 position by a cAMP-dependent protein kinase36. In this
manner, dematin differs from other large-IDR-containing cytoskeletal regulators which tend to
undergo covalent modifications on their unstructured segments. It also lacks the folded Nterminal core characteristic of villin-like proteins but still manages to interact with F-actin
through two binding sites, one located within its IDR and the other found on its headpiece.
While its phosphorylation state does not impact its F-actin-binding properties, its F-actinbundling capability is abolished upon headpiece phosphorylation34–36.

17

Figure 1.5.6. Structure of dematin (Homo
sapiens). A) Dematin has preserved the folded
headpiece domain characteristic of villin
proteins but lacks the gelsolin domain. It has
a large disordered region consisting of the
first 315 N-terminal residues. It has two
known actin-binding sites, one on its IDR and
one on the headpiece domain. One way to
regulate its activity is through
phosphorylation of S381. Point mutation
S381E was shown to mimic the phosphorylated state in terms of both structure and function.

Recent NMR studies of the dematin suggest that the phosphorylation of the headpiece may
trigger an intramolecular binding event between the headpiece and its IDR23 but the binding
interface remains uncharacterized (1.5.7). Such an interaction is further suggested by the
presence of the headpiece signature peaks irrespective of its phosphorylation state when its
102 N-terminal IDR portion is truncated. Peaks which proceed to disappear upon analysis of the
phosphorylation mimic and only do so in the presence of the full dematin IDR (Figure 1.5.8).

Figure 1.5.7. Hypothesized
intramolecular interaction
within dematin. Based on
15

N-HSQC data36, the
headpiece domain may be
involved in an
intramolecular binding
interaction with the
unstructured region upon phosphorylation of its S381 residue by protein kinase A (PKA). The
nature of this interaction, as well as the binding interface, remains unknown.
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Figure 1.5.836. N-HSQC of uniformly labeled dematin 2 (Homo sapiens). All spectra were
collected at 500MHz and 20 ℃. Dematin concentrations ranged from 20-50 µM. Buffer
composition for all samples consisted of 200 mM NaCl, 10 mM phosphate 10% D2O at pH
7.0. A) Full-length wild-type (WT) dematin (recombinant, rD). B) full-length phosphorylation
mimic dematin (rD-S381E). C) WT dematin lacking the first 102 N-terminal IDR residues
(truncated, tD). D) phosphorylation mimic dematin missing the same 102 N-terminal portion
(tD-S381E). Headpiece signature peaks disappear upon phosphorylation only when the 102
N-terminal IDR segment is present.

19

Disruptions of the dematin gene is associated with multiple health disorders. Mice in which the
dematin headpiece was truncated produced osmotically fragile red blood cells with
compromised semi-permeability leading to their developing hemolytic anemia37. Moreover,
prostate, breast, colon, and bladder cancer patients often lack the dematin genes38. Recent
findings have demonstrated that reintroduction of the dematin gene reverted cancerous
prostate cells to their normal healthy state1,7,8,38. Because of its role in tumor suppression,
characterizing dematin’s intramolecular interface will enrich our current understanding of
cancer and contribute to the advancement of biomedical research.
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1.6 Thesis Aims:
This works aims to achieve the following goals in investigating the properties, function, and
interactions of large IDR-containing cytoskeleton regulators:
I. Develop and optimize procedures to synthesize large IDR-containing proteins via
Sortase-Mediated Ligation (SML).
II. Segmentally label dematin (Homo sapiens) via SML to characterize its intramolecular
binding interface.
III. Optimize the in vitro synthesis of the full-length villin 4 IDR (Arabidopsis thaliana)
through SML.
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Chapter II: Materials and Methods:
2.1 Chemical Supplies:
All buffers and solutions were made from chemical reagents obtained from commercial
vendors. The water used in these preparations was filtered with a Milli-Q Advantage A10
system (Millipore).
2.2 Plasmid Design:
All Aim I proteins, dematin, and villin 4 constructs discussed were provided in pET-24a(+)
vectors by GenScript. Genes for wild-type and hepta-mutant sortase A (7m-srtA) were
incorporated into pET-30b(+) plasmids and issued by the Hidde Ploegh Laboratory. Aim I
hexapeptides were generated via solid-phase peptide synthesis and provided by Antos lab,
Department of Chemistry.
2.2a Design of Aim I Constructs:
Starting from the N-terminal end, all Aim I proteins contain an FH8 solubility and purification
tag, a TEV cleavage site, a poly-glycine/serine spacer, the authentic IDR sequence under
investigation (five residues constituting the N-terminal flanking region relative to the sortase
site), the LPXTG motif, an additional glycine to improve the SML reaction rate, and a histidine
affinity tag for purification purposes (Figure 2.2.1)

Figure 2.2.1. Structure of the SML N-terminal ligation partner.
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All Aim I hexapeptides are composed of an N-terminal glycine nucleophile, followed by an
authentic IDR sequence (five residues representing the C-terminal flanking region to the LPXTG
site), and 2,4-dinitro-phenyllysine or K(DNP) as the chromophore (Figure 2.2.2).

Figure 2.2.2. Structure of the SML C-terminal ligation partner.

All authentic IDR sequences were found in the DisProt database. To generate the LPXTG sortase
site, two point-mutations were generated within these true IDR sequences. These mutations
differ depending on the construct but are indicated appropriately in the corresponding figures
throughout this document. The extra glycine and His6 found in aim I proteins are absent from
the final ligation product.
2.2b Design of Aim II Constructs:
Dematin IDR: From the N-terminal end, contains a twin strep tag, glycine spacer, TEV cleavage
site, IDR sequence(1-300), the LPSTG sortase site, originally LQSTE in WT dematin, an additional
glycine, and a His6 affinity tag (Figure 2.2.3).

Figure 2.2.3. Structure of dematin IDR construct.
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Dematin HP (P): Dematin headpiece (phosphorylation mimic) is composed of an N-terminal His6
followed by a TEV cleavage site, and the headpiece sequence containing the S381E mutation to
mimic phosphorylation by protein kinase A (PKA) (figure 2.2.4).

Figure 2.2.4. Structure of the mutant dematin headpiece construct. The S381E mutation
mimics the phosphorylated state in terms of structure and function. This segment
encompasses residues 306-383.
Dematin HP: Wild-type dematin headpiece (unphosphorylated). Same design as the dematin
HP (P) but contains the native serine at position 381 (Figure 2.2.5).

Figure 2.2.5. Structure of the wild-type dematin headpiece construct. This segment
encompasses residues 306-383.
Dematin C-IDR-HP: Starting from the N-terminus, a His8 followed by a TEV cleavage site and the
C-terminal end of dematin IDR attached to the wild-type headpiece sequence (residues 161383) (Figure 2.2.6).

Figure 2.2.6. Structure of C-IDR-HP. This SML C-terminal ligation partner contains the Cterminal portion of the dematin IDR attached to the wild-type headpiece. This segment
encompasses residues 161-381.
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Dematin N-IDR: From the N-terminus, twin strep tag followed by a TEV cleavage site, then the
N-terminal portion of dematin IDR (residues 1-160). This fragment contains two mutations,
S156L and K160G (Figure 2.2.7).

Figure 2.2.7. Structure of N-IDR. This SML C-terminal ligation partner contains the N-terminal
portion of the dematin IDR. This segment encompasses residues 1-160 (when counting
amino acids in the SML site).
As in Aim I constructs, the last glycine and His6 at the C-terminal end of the IDR fragment do
not appear in the ligation product.
2.2c Design of Aim III Constructs:
AtV4IDR: Villin 4 full-length IDR from the N- to C-terminus includes a twin strep tag, a polyglycine spacer, the IDR sequence, a diglycine spacer, a His8 affinity tag. Residues of suspected
PEST motif within positions 866-873 changed from SPAPESNS to AAAGGGAG (Figure 2.2.8).

Figure 2.2.8. Structure of AtV4IDR.

AtV4IDR-B: The basic portion of the IDR flanked on its N-terminal side by a twin strep tag,
followed by a poly-glycine spacer, and a TEV cleavage site. At the C-terminal side, the suspected
PEST motif was mutated from APESNS to LPETGG followed by His8 . The mutations aimed at
creating a sortase recognition site and minimizing proteolytic cleavage. The second glycine and
His6 are not part of the final ligation product (Figure 2.2.9).
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Figure 2.2.9. Structure of AtV4IDR-B.

AtV4IDR-A-HP: Contains the acidic portion of the V4 IDR attached to the folded headpiece
domain, included to provide stability. The N-terminus of this protein fragment includes a twin
strep tag, a poly-glycine spacer, a His8 tag, and a GG sequence, initially NS in the suspected PEST
motif, and a TEV cleavage site (Figure 2.2.10).

Figure 2.2.10. Structure of AtV4IDR-A-HP.

2.2d Enzymes Used in the Experimental Protocols:
See Appendix section 1 for enzymes used and corresponding amino acid sequences.
2.3 Bacterial Transformation:
All constructs referenced were transformed into BL21 (DE3) E. coli cells obtained from
GOLDBIO. The competent cells (50 μL) were first thawed on ice for 15 minutes upon retrieval
from the -80C freezer. Following the addition of ~1 pg of plasmid DNA, the cells were incubated
on ice for 30 minutes before undergoing heat shock at 42 ℃ for 45 seconds. Subsequently, the
cells were placed on ice for 2 minutes, mixed with 950 μL of Luria Broth (LB) media (10g/L Bacto
tryptone, 10g/L NaCl, 5g/L yeast extract) then incubated in a shaker at 37 ℃ and 210 rpm for 1
hour to recover prior to being plated onto solid agar media (LB composition, 15 mg/mL
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granulated agar) containing kanamycin (10 μg/mL) as the selective agent. These plates were
then incubated at 37 ℃ overnight (12-17 hours).
2.4 Bacterial Growth and Protein Expression:
2.4a Regular Growth and Expression:
All constructs were expressed in BL21 (DE3) E. coli cells. These cells were grown in 1 L LB media
(37 ℃, 210 rpm) and induced with 1 mL of 0.8 M IPTG when an optical density (O.D.) of 0.5-0.7
was reached. 4-6 hours following IPTG induction, the cell culture was centrifuged at 4 ℃,
4629 x g for 20 minutes, the LB was discarded and the pellet was stored at -80 ℃.
2.4b Bacterial Growth in Minimal Media (M9):
When isotopically labeled constructs are generated, they will be made in BL21 (DE3) E. coli
strains cultured in minimal media according to our established procedure: cells are first added
to LB media (37 ℃, 210 rpm). Upon reaching an O.D. of 0.4-0.5, they are centrifuged at 4000 x g
for 20 minutes at 4℃ then resuspended in 500 mL of salt wash for each 6 L LB media growth (6
g/L Na2HPO4 , 3 g/L KH2PO4, 0.5 g/L NaCl, 200 g/L vitamin B1, 120 g/L MgSO4, 28 g/L CaCl2, 10
mg/L kanamycin). Upon resuspension, the cells are subject to another centrifugation* step at
4000 x g for 20 minutes at 4℃ before being suspended in minimal media M9 which contains
the sources for carbon and nitrogen (identical salt wash composition, 3 g/L 15NH4Cl, 6 g/L 13C-DGlucose). Following 1 hour of incubation at 37 ℃, they are induced with 2 mL of 0.8M IPTG per
liter of culture and incubated for 4 hours at 210 rpm, 37℃. Finally, the culture is spun down for
15 minutes at 4629 x g and 4℃. The supernatant is discarded and the pellets are stored at
either -80℃ or -20℃ awaiting lysis.
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*All centrifugation steps are performed using a Sorvall Lynx 4000 centrifuge, Thermo Scientific,
rotor: F12-6x500 LEX, PN 096-062375.
2.5 Lysate Preparation:
2.5a Aim I and III protein lysate:
10mL of lysis buffer* was added to pellets harvested from a 1L growth. Upon resuspension, 10
µL of stock lysozyme (50 mg/mL) was added and agitated at 15 rpm 4℃ for 30 minutes. This
incubation was followed by three sonication rounds of 30 seconds each at 50% duty cycle using
a Branson Sonifer instrument. DNase I was added to the lysate to a final concentration of 0.1
units/mL. After an incubation period of 30 minutes at room temperature, the lysate was subject
to centrifugation for 30 minutes at 4℃ and 39,375 x g. The supernatant was passed through a
0.22µm filter in preparation for purification.
*Lysis buffer composition for Aim I proteins: pH 7.5, 150mM NaCl, 50mM Tris. Lysis buffer used
with Villin 4 fragments: pH 8.0, 300mM NaCl, 50mM NH2PO4, 10mM Imidazole.
2.5b Aim II Protein Lysate:
10 mL of lysis buffer* was added to pellets obtained from a 1L growth. The lysate was sonicated
for four 10 seconds intervals at 50% duty cycle with 10 seconds of cooling between each
sonication round. The lysate was left overnight stirring at 4 ℃ then spun down at 4 ℃ and
39,375 x g or 1 hour. Like all lysate, it was filtered with 0.22µm filter prior to chromatography.
*When IMAC was performed immediately following the lysate preparation IMAC solubilizing
buffer was used to lyse the bacterial cells (6M Urea, 50mM NaH2PO4, 300mM NaCl, pH 8).
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When Strep Tactin XT affinity purification was performed first, Buffer W (6M urea, 300 mM
NaCl, 50mM NaH2PO4, 20mM Imidazole, pH 8) served as the lysis buffer instead.
2.6 Protein Purification:
2.6a Aim I Proteins:
All Aim I proteins were purified using immobilized metal affinity chromatography (IMAC). All
IMAC purification was done with QIAGEN nickel nitrilotriacetic acid (Ni-NTA) Superflow resin. 1
column volume (CV) or 3mL* of Ni-NTA resin was left agitating gently at 15 rpm with the
filtered lysate for 1 hour at 4℃. Once the flow-through was collected, the resin was washed
with 8 CV of IMAC wash buffer (pH 7.5, 150 mM NaCl, 50 mM Tris-base, 20 mM imidazole). The
protein of interest was then eluted with 10 CV of IMAC elution buffer (pH 7.5, 150 mM NaCl,
50mM Tris-base, 300 mM imidazole)
*The column volume mentioned applies to a lysate obtained from a 1L expression growth.
2.6b. Aim II Purification:
All dematin constructs containing a strep and a His6/8 affinity tag are purified via IMAC
immediately followed by Strep affinity chromatography (SAC). IMAC was performed following
the procedure described in section 2.6a. For dematin constructs however, 15 CV of IMAC wash
buffer (pH 8, 2 M urea, 300 mM NaCl, 50mM NaH2PO4, 20 mM imidazole) and 9 CV of IMAC
elution buffer (pH 8, 2 M urea, 50 mM NaH2PO4, 250 mM imidazole, 300 mM NaCl) were used.
SAC purification was performed using IBA Strep Tactin XT 4flow resin. 1 CV or 2 mL* of strep
tactin XT was mixed with the IMAC elutions. After collecting the flow through, the resin was
washed with 15 CV of buffer W (pH 8, 2 M urea, 100mM Tris-HCl, 150mM NaCl, 1mM EDTA)
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and the protein was eluted in 10 CV of Buffer BXT (pH 8, 2 M urea, 100mM Tris, 150mM NaCl,
1mM EDTA, 100 mM biotin). The resin bed should not be disturbed or agitated in anyway. No
incubation period with the lysate is required for binding to occur.
Dematin headpiece fragments are purified via two rounds of IMAC using the above-mentioned
volumes for wash and elution fractions. Thus, IMAC was done before and after the TEVcleavage reaction to which they are subject prior to their ligation with the rest of the dematin
protein (the IDR). Moreover, the relative stability of both headpieces eliminates the need of
urea in the buffers used for their purification, storage, and analysis.
*The column volume mentioned applied to a lysate obtained from a 1L expression growth.
2.6c Aim III Purification:
All villin 4 fragments follow an identical purification regimen as dematin fragments except that
no urea is used in the IMAC and strep buffers.
2.7 TEV-Cleavage Reactions:
In order to expose the N-terminal glycine nucleophile required for sortase-mediated ligation, all
dematin and villin 4 headpiece (HP) constructs underwent a TEV cleavage. The total reaction
volume ranged from 1-5 mL. The final reaction mixture contained 1 mM DTT, 0.5 mM EDTA, 1
µM of TEV protease for every 90 µM of headpiece. The reaction was incubated at room
temperature for 16 hours in PIPES buffer (pH 6.8, 50 mM NaCl, 20 mM PIPES) then purified via
IMAC using 250 µL of Ni-NTA resin. The flow-through was collected and the resin was washed
with 8 CV of PIPES buffer followed 4 CV of IMAC elution buffer (pH 8, 50 mM NaH2PO4, 250 mM
imidazole, 300 mM NaCl). The flow through and the wash were typically combined as they
contained the pure cleaved Headpiece constructs which were ready for ligation.
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2.8 Sortase-Mediated Ligation (SML):
2.8a Aim I SML:
All ligation reactions utilized 20 µM of wild-type sortase A (Staphylococcus aureus) and were
monitored for 8 hours at room temperature and pH 7.5, in 150 mM NaCl and 50 mM Tris-base
buffer spiked with 10 mM Ca2+ and 1 mM TCEP. The protein substrate and hexapeptide
nucleophile were present at 50 µM and 250 µM, respectively. The total reaction volume was
100 µL.
2.8b Aim II SML:
All ligation reactions between dematin’s IDR and TEV-cleaved headpiece fragments utilized 5
µM of hepta-mutant sortase A (7m-srtA). They were incubated for 4-48 hours at room
temperature and pH 8 in 20 mM imidazole, 50 mM NaH2PO4, 300 mM NaCl and 0-2 M urea
buffer. The reaction volume varied between 0.5-3 mL. The molarity of the TEV- cleaved
headpiece construct exceeded that of the IDR by a factor of 5 as the headpiece levels were kept
around 120 µM while the IDR was measured to be about 24 µM. Throughout these optimization
experiments, the only data collected was for the ligation of the TEV-cleaved phosphorylated
headpiece to the IDR.
2.8c Aim III SML:
The ligation between AtV4IDR-B and AtV4IDR-A-HP was incubated for 24 hours at room
temperature and pH 8 in 100 mM Tris-base, 150 mM NaCl, 1 mM EDTA, and 100 mM biotin. 6
µM of 7m-srtA was used with 40 µM AtV4IDR-A-HP and 30 µM TEV- cleaved AtV4IDR-B
Purification of the ligation product from other reaction components was attempted using IMAC
and SAC. The only difference resides in the volume of resin used. To isolate the ligation product,
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200 µL of Ni-NTA and strep tactin XT were typically used for reaction mixtures ranging from 1-5
mL in volume. Size-exclusion chromatography (SEC) was also utilized as either an alternative or
a complement to IMAC and SAC.
2.9 Size-Exclusion Chromatography (SEC):
Occasionally, the proteins expressed were further purified through SEC in which a HiPrepTM
16/60 SephacrylTM S-100 HR column (120 mL CV, GE Healthcare) was attached to an ÄKTAprime
plus FPLC system (GE Healthcare). Proteins were eluted in PIPES buffer (pH 6.8, 20 mM PIPES,
50 mM NaCl) which contained 2 M urea for dematin constructs at a flow rate of 0.5mL/min.
2.10 Buffer-Exchanging Protein Samples:
Aim I proteins were buffer-exchanged into 150 mM NaCl, 50mM Tris-base at pH 7.5 preceding
ligation with their corresponding hexapeptides using disposable Econo-Pac 10DG desalting
columns from BIO-RAD. The column was equilibrated with 20 mL of 150 mM NaCl, 50mM trisbase buffer at pH 7.5. A 3 mL-sample was then added to the column. After the flow through
was collected, the protein was eluted in 4-12 mL of 150 mM NaCl, 50mM Tris-base buffer at pH
7.5. All other buffer-exchange procedures involving dematin or villin 4 fragments were
performed via dialysis.
2.11 Protein Quantity and Purity Assessment:
Protein quantification was achieved through measuring absorbances at 280 nm with a
NanodropTM ND-1000 spectrophotometer (ThermoFisher).
Their extinction coefficients were obtained in Expasy ProtParam and their molarity calculated
using Beer-Lambert law. Protein concentration was achieved through Thermo Scientific Pierce
spin concentrators with 3000 Da MWCO (all samples) spun in the Thermo scientific Sorvall
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Legend X1R centrifuge (rotor# 75003181). In addition to using spin concentrators, dematin (P)
LP was concentrated via lyophilization with Labconco FreeZone Lyophilizer 2.5 L. Protein purity
was determined via 15% SDS-PAGE and their identity was confirmed through Mass
Spectrometry (MS). In this document, concentrations given for the protein fragments discussed
are typically for the most concentrated fraction obtained from a 1-3L bacterial growth.
2.12 Identity Verification: Mass Spectrometry (MS)
2.12a Liquid Chromatography Electrospray Ionization Mass Spectrometry (LC-ESI-MS)32,39:
Identity of protein samples was confirmed through liquid chromatography electrospray
ionization mass spectrometry (LC-ESI-MS). Such experiments were done using Advion CMS
expressionL mass spectrometer and a Dionex Ultimate 3000 HPLC instrument to which a
Phenomenex Aeris 3.6 μm WIDEPORE C4 200 Å column (100 x 2.1 mm) was attached. The
mobile phase consisted of 95% H2O, 5% MeCN, and 0.1% formic acid and organic MeCN and
flowed at a rate of 0.3 mL/min. For villin 4 and dematin headpiece fragments (settings: keep at
10% organic for 1.0 min, linear gradient of 10–90% organic from 1.0–7.0 min, keep at 90%
organic 7.0–9.0 min, linear gradient of 90–10% organic 9.0–9.1 min, re-equilibrate at 10%
organic 9.1–12.0 min). The protein charge ladders were deconvoluted with Advion Data
Express or Analyst 1.4.2 software. This same method is also described in Erin Rosenkranz’
thesis39 (OCLC# 1277514139) as well as our latest published manuscript (PMID# 34710113)32
2.12b Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry (LC-QTOF-MS)39:
For Dematin’s IDR segment as well as the final ligation product, identity was checked using
liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). This
analysis was carried through with Agilent AdvanceBio 6545XT LC/QTOF mass spectrometer and
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an Agilent 1290 Infinity II UHPLC to which a Phenomenex AerisTM 3.6 μm WIDEPORE C4 200 Å
column (100 x 2.1 mm) was attached. The mobile phase consisted of 95% H2O, 5% MeCN, and
0.1% formic acid and organic MeCN at a rate of 0.3 mL/min (settings: keep at 10% organic for
1.0 min, linear gradient of 10–90% organic from 1.0–7.0 min, keep at 90% organic 7.0–9.0 min,
linear gradient of 90–10% organic 9.0–9.1 min, re-equilibrate at 10% organic 9.1–12.0 min). The
samples’ charge ladders were deconvoluted with Agilent BioConfirm software. This same
method is also described in Erin Rosenkranz’ thesis39 (OCLC# 1277514139)
2.13 Solution Nuclear Magnetic Resonance (NMR) Spectroscopy:
When protein samples are ready for NMR analysis, they will be buffer-exchanged into PIPES
buffer (pH 7.5, 20 mM PIPES, 50-200 mM NaCl) and spiked with EDTA, D2O, and NaN3 to a final
concentration of 0.5mM, 8%, and 0.02%, respectively. 15N-HSQC spectra will be acquired
through Bruker Avance III HD NMR spectrometer operating at a magnetic field of 11.7 Tesla.
Chapter III: Results and Discussion:
3.1 Aim I Results and Discussion:
Aim I: Develop and Optimize Procedures to Synthesize Large IDR-Containing Proteins via
Sortase-Mediated Ligation (SML).
The IDR sequences to be reconstructed via SML were found in the DisProt database which
contains over 625 IDRs greater than 100 residues (table 3.1.1) . Using SLIDRs (sortase ligation
for intrinsically disordered regions), a software co-developed by Dr. Sergey Smirnov and Dr.
John Antos from the Chemistry department at Western Washington University, potential SML
sites were identified within the IDR sequences analyzed. Within the 625 large IDRs found in
DisProt, only 4 native LPXTG sites were found. Upon specifying in SLIDRs the number of point34

mutations required to generate an LPXTG motif, 301 additional sites became available through
the incorporation of 1 point-mutation, this number further increased to 8147 if up to 2
mutations were to be introduced into these IDR sequences.
Table 3.1.1. SML Sites Identified in DisProt IDRs using novel SLIDRs software.

In the case of the IDR constructs chosen for this study, we limited the number of amino acid
substitutions to 2 in order to minimize the impact these changes may have on structure,
function, and behavior of the IDRs under investigation. Thus, 12 ligation systems were initially
designed to be compared in terms of their SML conversion rate from substrate to product
under the same reaction conditions. Specifically, our efforts aim at assessing how the identity of
residues (acidic, basic, aromatic aliphatic, etc.) surrounding the LPXTG site affects SML
efficiency as we attempt to reconstitute IDR sequences (Figure 3.1.2). Each system is composed
of a protein as the N-terminal ligation partner and a hexapeptide as a C-terminal substrate. All
proteins include an LPXTG motif preceded by a five-residue IDR sequence representing the Nterminal flanking region to sortase site (Figure 3.1.1). All hexapeptides synthesized include an
N-terminal glycine nucleophile followed by a five-residue IDR motif constituting the C-terminal
flanking region to the sortase recognition signal. In addition to these ligation systems, a positive
glycine control was designed to serve as our reference. In this scenario, the N- and C-terminal
flanking regions are composed of a pentaglycine motif. Indeed, sortase enzymes typically
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demonstrate a high degree of efficiency when glycine residues surround the LPXTG
sequence32,40. Due to the collaborative nature of this work, only some systems which reflect the
author’s direct contribution to this aim will be discussed in this document.

Figure 3.1.1. Evaluation of SML reaction efficiency under various N- or C-terminal contexts.
Authentic IDR sequences are reconstructed in vitro through SML. 0-2 point mutations are
performed in these true IDR sequences to create the LPXTG sortase recognition sites. The Nterminal IDR portion is expressed in E .coli BL21 (DE3) and includes the N-terminal flanking
residues. TEV-cleavable FH8 and His6 tags are incorporated to allow for purification and improve
solubility (FH8). The hexapeptide constitutes the C-terminal ligation partner and contains an Nterminal glycine nucleophile, the C-terminal flanking region, and a chromophore to aid in
tracking and yield determination. The flanking regions assessed for their impact on SML
reaction rate were chosen for their acidic, basic, aromatic, aliphatic, hydrophobic, polar, or
proline-rich properties. All ligation reactions in aim I were performed with Wild-type sortase A
(staphylococcus aureus)
3.1.1 Proline-rich C-terminus (ProC):
The proline-rich C-terminus (ProC) system evaluates the impact a pentaproline stretch
downstream of the LPXTG motif makes on SML rate. Here, valine and alanine found in the wildtype IDR sequence were mutated to proline and glycine, respectively to create the sortase A
recognition signal (Figure 3.1.2). On average 35% of the protein substrate was ligated to the
corresponding hexapeptide, around 2.5-fold lower efficiency relative to the glycine control
which was found to produce 80% ligation product (Figure 3.1.3).The control was designed to
contain poly-glycine stretches based on the known high performance of sortase enzymes in the
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presence of glycine residues surrounding the LPXTG sorting motif40. In the ProC system, 23 % of
the protein substrate was lost to competing reactions. As suggested by LC-ESI-MS, hydrolysis
and potential intramolecular events are suspected to occur.

Figure 3.1.2. Sortase-mediated ligation in the presence of a C-terminal pentaproline motif.
A) Structure of the ligation product, ProC (LP). Mutated residues are underlined, wild type
amino acids (aa) are denoted directly underneath the substitution site. B) 15 % SDS-PAGE of Nterminal ligation partner ProC following IMAC purification. C) Percent ProC successfully ligated
to the corresponding hexapeptide to form ProC (LP). D) LC-ESI-MS spectrum of ProC and ProC
(LP).
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Figure 3.1.3. Sortase-mediated ligation of glycine control. A) Structure of ligation product GlyC
(LP). B) 15% SDS-PAGE of glycine N-terminal ligation partner. C) Percent glycine protein ligated
to C-terminal pentaglycine substrate. D) LC-ESI-MS spectrum of GlyC and GlyC (LP).

3.1.2 Aromatic C-terminus (AroC) and Aromatic N-terminus (AroN):
In Aromatic C (AroC), the native lysine and cysteine were changed into leucine and threonine to
generate the LPXTG sequence which is followed by aromatic amino acids (YYHWD) in the
ligation product (Figure 3.1.4). A conversion rate of 5 % was determined after 8 hours of
monitoring. Given identical reaction conditions, the 17-fold decrease in ligation efficiency
compared to the glycine control (Figure 3.1.3) can be attributed to the amino acid composition
around the LPXTG site. Whether the N- or C-terminus context is responsible for the massive
drop in substrate conversion rate is still unclear. An unexpected peak around 11146 Da was
detected and may be the product of a side reaction that has yet to be identified.
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Figure 3.1.4. Sortase-mediated ligation in the presence of aromatic residues downstream of the
LPXTG site. A) structure of the ligation product, AroC (LP). Mutated residues are underlined, wild
type amino acids (aa) are denoted directly underneath the substitution site. B) 15% SDS-PAGE of
N-terminal ligation partner AroC following IMAC purification. C) Percent AroC converted to
ligation product AroC (LP). D) LC-ESI-MS spectrum of AroC and AroC (LP).

In contrast to AroC, aromatic N-terminus (AroN) contained an aromatic motif (WHIWW)
upstream of the LPXTG site, originally LAIVG in the wild-type IDR sequence (Figure 3.1.5). No
ligation product was detected for this system. No undesired products were made. Similar to
AroC, our current data is insufficient to determine with certainty which of the N- or C-terminal
motif is impeding the SML reaction.
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Figure 3.1.5. Sortase-mediated ligation in the presence of an aromatic motif upstream of the
LPXTG site. A) Structure of potential ligation product AroN (LP). Mutated residues are
underlined, wild type amino acids (aa) are denoted directly underneath the substitution site. B)
15 % SDS-PAGE of N-terminal ligation partner AroN following IMAC purification. C) LC-ESI-MS
spectrum of sample reaction mixture, no AroN (LP) detected.

3.1.3 Polar-Charged N-terminus (PolN):
Polar charged N-terminus (PolN) incorporated polar charged residues (DRIKE) immediately
before the sortase site in which a threonine and glycine have replaced the native leucine and
tryptophan, respectively (Figure 3.1.6). While this system performed better than AroC and
AroN (section 3.1.3), it remained suboptimal compared to the glycine control (Figure 3.1.3).
Indeed, in the polyglycine reference reaction, the extent of ligation using WT-srtA was found to

40

be be 3.5-fold higher relative to the PolN context, which exhibited an overall conversion of only
22%. Competing reactions contributed to the loss of ~13 % of the initial PolN protein substrate.
Like in ProC, these undesired side reactions are suspected to be hydrolysis of the protein
substrate and some uncharacterized intramolecular event.

Figure 3.1.6. Sortase-mediated ligation in the presence of N-terminal polar charged residues
before the LPXTG site. A) Structure of ligated product PolN (LP). Mutated residues are
underlined, wild type amino acids (aa) are denoted directly underneath the substitution site. B)
B) 15% SDS-PAGE of N-terminal ligation partner PolN following IMAC purification. C) Percent
PolN converted to ligation product PolN (LP). D) LC-ESI-MS spectrum of PolN and PolN (LP).

Interestingly, upon ligating the N-terminal protein partner with a pentaglycine control as the Cterminal substrate at 37 ℃, the reaction conversion reached 92% after 8 hours (Figure 3.1.7),
exceeding that of the glycine control performed at room temperature (Figure 3.1.3). The near
4-fold increase in ligation efficiency cannot be attributed to the temperature change alone,
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because when the initial experimental constructs (Figure 1.3.6, panel A) were ligated at 37 ℃,
there was no significant change in the success of the reaction. Thus, the substitution of the Cterminal flanking region LGQNE into a pentaglycine stretch likely caused the increase in ligation.

Figure 3.1.7. Sortase-mediated ligation between N-terminal polar residues and C-terminal
pentaglycine. A) Structure of ligation product PolN-5Gly. Mutated residues are underlined, wildtype amino acids (aa) are denoted directly underneath the substitution site. B) Percent
conversion of PolN into polN-5Gly. C) LC-ESI-MS spectrum of PolN and PolN-5Gly.

To further support this conclusion, a protein containing a pentaglycine as the N-terminal
flanking region instead of the native DRIKE IDR sequence was ligated to the GLGQNE
hexapeptide. With these reactants, only 14% of the protein substrate was converted to the
product (5GlyN-PolN) via SML (Figure 3.1.8), confirming that the presence of the C-terminal
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sequence LGQNE is the culprit for poor sortase performance. To note, the reactions depicted in
Figures 3.1.7 and 3.1.8 have been performed only once, unlike all other ligations discussed
which were done in triplicates.

Figure 3.1.8. Sortase-mediated ligation between N-terminal pentaglycine and C-terminal PolN
ligation partners. A) Structure of ligation product 5GlyN-PolN. Mutated residues are underlined,
wild-type amino acids (aa) are denoted directly underneath the substitution site. B) Percentage
of N-terminal glycine control that ligated with the C-terminal partner normally associated with
PolN. C) LC-ESI-MS spectrum of ligation product 5GlyN-PolN.

3.1.5 Future Works in Aim I:
WT-srtA appears to operate at significantly suboptimal levels in all systems currently under
investigation compared to the positive glycine control. Because all reactions, including the
controls, were carried out under identical conditions, any deviation from the mean reference
conversion of 80% can only be explained by the differences in sequence surrounding the
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sortase ligation site. In order to determine which amino acid(s) in the N- or the C-terminal
flanking region is(are) responsible for the decrease in ligation efficiency, each SML partner
(protein and hexapeptide) will eventually be ligated to a glycine control acting as either the Nterminal or the C terminal ligation partner. Additionally, the use of increasingly larger glycine
spacers between the ligation site and the problematic flanking regions may be warranted to
assess the proximity necessary for these residues to impede the ligation reaction. Other
parameters such as buffer composition, pH, and temperature may be altered as well in an
effort to improve the product yield. The use of different sortase variants which may offer higher
substrate affinity or the ability to recognize different ligation sites19,20,22 are currently under
consideration but issues related to competing hydrolysis are expected41.
3.2 Aim II Results and Discussion:
Aim II: Segmentally Label Dematin (Homo sapiens) via SML to characterize its intramolecular
binding interface.
Through analysis of the dematin sequence via SLIDRS, multiple potential sortase ligation sites
were identified when up to two amino acid substitutions are allowed (Figure 3.2.1). Examples
of these possible sortase motifs include positions 78-82, 156-160, and 301-305. The constructs
discussed in this work will focus on the LPXTG site at position 301-305. To this end, the native
sequence underwent two point mutations, Q302P and E305G. Because of the location of this
ligation site, dematin’s IDR ends up representing the N-terminal ligation partner while the
folded headpiece constitutes the C-terminal SML substrate thus providing the required Nterminal glycine. Two different headpiece constructs were generated, the wild-type and the
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phosphorylation mimic. The phosphorylation mimic contains an additional mutation S381E,
emulating the protein’s behavior, structure, and function when it is phosphorylated41. While
ligation reactions will eventually also involve the wild-type headpiece and the IDR, the
phosphorylation mimic headpiece was used throughout these optimization experiments
because of the stability of the final ligation product.

Figure 3.2.1. Synthesis of a segmentally labeled Dematin. A) sequence of dematin isoform 2
(Homo sapiens). Highlighted motifs represent potential SML sites upon introduction of 2 point
mutations. Underlined residues are part of the folded headpiece domain, the remaining
residues constitute the IDR. B) Table listing positions of possible SML sites, showing both wildtype and corresponding mutant sequences.
Both the wild-type (Figure 3.2.2) and mutant headpiece (Figure 3.2.3) were successfully
expressed, purified, and TEV-cleaved to expose their N-terminal glycine nucleophiles required
for SML. 15-25mL of ~ 0.45 mM could generally be produced from a 3L-bacterial growths. The
IDR was produced separate from the headpiece and stored in 2M urea (Figure 3.2.4). Typically
2-4 mL of dematin’s IDR at 40-50 µM could easily be obtained from a 1L- bacterial growth.
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Figure 3.2.2. Dematin’s wild-type TEV-cleaved headpiece domain (TEV-HP). A)
15% SDS-PAGE of TEV-HP. B) LC-ESI-MS spectrum of dematin TEV-HP
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Figure 3.2.3. Dematin’s mutant TEV-cleaved headpiece domain (TEV-HP (P)). This
headpiece contains S381E mutation to mimic phosphorylation (P). A) 15% SDS- PAGE
of TEV-HP (P). B) LC-ESI-MS spectrum of dematin TEV-HP (P).
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Figure 3.2.4. Dematin’s IDR construct. A) 15% SDS-PAGE of dematin’s IDR after
strep and IMAC tandem purifications. B) LC-ESI-MS spectrum of dematin’s IDR.
All SML reactions were performed using hepta-mutant sortase A (7m-srtA) because of its
enhanced activity relative to WT-srtA. Urea up to 2 M in concentration was often used as a
denaturing agent to minimize proteolytic degradation of the IDR-containing SML substrate and
product without having any major effect on ligation efficiency. (See Appendix Figure 2.3 for
SML control reaction).
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Figure 3.2.5. Synthesis and purification of full-length dematin (P) LP construct (phosphorylation
mimic). A) Structure of dematin (P) (LP). B) SML reaction between the mutant dematin
headpiece (S381E) and IDR was incubated for 24 hours. The reaction mixture was then purified
via IMAC and SAC. The pure LP is indicated with a red arrow.

While the reaction was successful (Figure 3.2.5), difficulties were encountered when
attempting to purify the ligation product. To achieve this end, a two-step process was designed:
IMAC followed by Strep-Tag purification. While this was a promising purification method, a
significant amount of ligation product remained bound to both the strep and Ni-NTA resin,
leading to significant losses in yield (Figure 3.2.6). Furthermore, the majority of the ligation
product collected could not be separated from the excess unreacted headpiece constructs and
residual sortase enzyme. These issues were exacerbated when the purification steps were done
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in the absence of urea, for reasons that may be related to the poor solubility of full-length
dematin.

Figure 3.2.6. 15% SDS-PAGE of Ni-NTA and Strep resin following IMAC and strep purification of
dematin (P) LP in SML reaction mixture. Ni-NTA and strep resin was sampled after each step
performed as part of IMAC and Strep-Tag purification protocols (flow through (FT), wash, and
elution collection).

Because only 3 µM dematin (P) LP could be isolated from this two-step purification process,
size-exclusion chromatography (SEC) was attempted in order to separate the components of
the reaction mixture in an effort to improve product yield (Figures 3.2.7 and 3.2.8).
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Figure 3.2.7 Purification of dematin SML reaction mixture via size-exclusion chromatography
(SEC). SEC chromatogram of SML reaction mixture. The protein samples are eluted at pH 6.8 in 2
M urea, 20 mM PIPES 50 mM NaCl. Each peak corresponds to a specific component indicated in
the above graph. Peak 1 is collected over 3 separate fractions (1/3, 2/3, 3/3) while peak 2 and 3
span two fractions each (1/2, 2/2).
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Figure 3.2.8. 15% SDS-PAGE of collected SEC fractions. See Figure 3.2.7. A) Peak 1 is collected
over 3 separate fractions (1/3, 2/3, 3/3) while peak 2 and 3 span two fractions each (1/2, 2/2).
B) LC-ESI-MS spectrum of fraction containing peak 1 (1/3)

While SEC successfully separated sortase and headpiece from the ligation product, it could not
isolate it from the unreacted IDR construct due to proximity in molecular weight (38.4 KDa IDR,
46.4 KDa LP). Another issue involves the dramatic dilution incurred by the ligation product.
Initially in a 1-mL-reaction, it was now collected as part of a 25-mL-fraction. LC-QTOF-MS
analysis of the SEC fraction containing the first third of peak 1 (Figures 3.2.7 and 3.2.8) detected
a peak at 46486 Da which is 239 Da over the expected mass of 46247 Da for the ligation
product. While we suspect the presence of non-covalent adducts (e.g. Na+) to contribute to this
mass discrepancy, instrument accuracy may be low due to overall low signal intensity. Attempts
to concentrate the ligation product in the above-mentioned SEC fraction was made:
centrifugation in Thermo Scientific Pierce spin concentrators as well as lyophilizationrehydration experiments were executed. Both cases resulted in an unexplained loss of the
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protein product. In the case of lyophilization, salts contained int the storage buffer (urea, PIPES,
and NaCl) were likely concentrated beyond the compatibility range for dematin (P) LP 37,42,43 ,
leading to its inevitable destabilization. Indeed, proteins are often unable to redissolve after
being lyophilized, suggesting they were denatured throughout this process44.
3.2.1 Future Works in Aim II:
The use of SEC allowed for the efficient separation of the headpiece construct and sortase
enzyme from the ligation product. This promising outcome led to the design of new fragments
utilizing the LPXTG site at 156-160 position (Figure 3.2.5).

Figure 3.2.9. Change of dematin constructs utilized. A) wild-type (WT) dematin sequence.
Potential LPXTG sites are highlighted in green. The headpiece sequence is underlined. B) Change
of LPXTG site used from positions 301-305 to 156-160 leading to novel segmentally labeled
dematin constructs possible. The LPXTG motifs shown are obtained upon 2 point-mutations to
the WT sequences indicated.
In this new scenario, a serine and a lysine are replaced by a leucine and a glycine, respectively.
With this change in mind, the fragment including the headpiece and the C-terminal IDR portion
(C-IDR-HP, 25 KDa when TEV-cleaved to expose the N-terminal glycine nucleophile) and the one
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composed of the N-terminal IDR segment (N-IDR, 21 KDa) will form a ligation product of about
46 KDa. Because 7m-srtA is around 18 KDa, this design should allow for easy separation of the
dematin LP from other SML components through SEC. Both dematin C-IDR-HP (~8 mL at about
97 µM) and N-IDR (~4 mL at about 32 µM) have been successfully produced from separate 1Lbacterial growths (Figures 3.2.6). They are currently undergoing optimization studies in term of
their yield, purity, and TEV-cleavage (for C-IDR-HP) before SML can take place. At the time of
writing this thesis, Mass spectrometry has yet to be performed on these two new fragments.

Figure 3.2.10. Production of New Dematin fragments, C-IDR-HP and N-IDR. A) structure and
15% SDS-PAGE of dematin C-IDR-HP purified through IMAC. The flow through (FT), wash (W)
and elution (E) fractions are shown. B) Structure of dematin N-IDR segment purified through
strep affinity chromatography (SAC), elution fractions collected from SAC underwent IMAC
purification.
Desalting the ligation product may also be considered prior to lyophilization to minimize sample
loss during the concentration process42,44. When successful isolation of the ligation product at
adequate yield (50-100 µM) is achieved, a segmentally labeled sample can then be made for
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analysis via solution NMR spectroscopy to investigate the suspected intramolecular interaction
between the phosphorylated headpiece and IDR.
3.3 Aim III Results and Discussion:
Aim III: Optimize the in vitro synthesis of the Full-Length Villin 4 IDR (Arabidopsis thaliana)
through SML.
To perform any structure characterization studies or actin binding assays, the full-length villin 4
IDR first needs to be synthesized and purified. Our ultimate goal is to decipher the mechanism
through which this disordered segment contributes to villin 4’s F-actin binding and bundling
activity. Such knowledge would help elucidate the way plant root growth is regulated. To
produce this IDR, two avenues were explored in parallel. The first one consisted of separately
expressing the acidic and basic stretch of the linker and ligating the two IDR portions via SML.
This strategy was initially favored because of the possibility of generating a segmentally labeled
sample for solution NMR analysis. The acidic portion attached to the folded headpiece
(AtV4IDR-A-HP) was successfully produced as ~3mL at 112 µM were made from a 1L-bacterial
growth (figure 3.3.1) and TEV-cleaved (Figure 3.3.2). While the TEV-cleaved AtV4IDR-A-HP
(TEV-AtV4IDR-A-HP) appears as 15-KDa band on a gel, analysis of this same sample via LC-ESIMS shows it to have a mass of 11984.7 Da which matches our expected calculated mass of
11983 Da when instrumental error is taken into account. Thus, in our lab, SDS-PAGE data is
typically only used to assess protein purity while MS is utilized confirm our constructs’ identity.
The basic part of the villin 4 IDR (AtV4IDR-B) was expressed and purified (~3 mL at around 88
µM/ 1L bacterial growth) in parallel to TEV-AtV4IDR-A-HP (Figure 3.3.3).
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Figure 3.3.1. Synthesis and purification of AtV4IDR-A-HP. A) structure of the AtV4IDR-A-HP
segment. B) 15% SDS-PAGE of AtV4IDR-A-HP. C) LC-ESI-MS of AtV4IDR-A-HP.
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Figure 3.3.2. Production of TEV-AtV4IDR-A-HP. A) structure of the TEV-AtV4IDR-A-HP
segment. B) 15% SDS-PAGE of TEV-AtV4IDR-A-HP. C) LC-ESI-MS of TEV-AtV4IDR-A-HP.
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Figure 3.2.3. Synthesis and purification of AtV4IDR-B. A) structure of the AtV4IDR-B segment.
B) 15% SDS-PAGE of AtV4IDR-B. C) LC-ESI-MS of AtV4IDR-B.

SML between AtV4IDR-B and AtV4IDR-A-HP utilized 7m-srtA and was monitored for 48 hours.
The ligation product has an expected molecular weight of 31.7KDa but 15% SDS-PAGE analysis
revealed one main band at around ~38 KDa absent in the controls and at the zero-hour
timepoint (Figure 3.3.4).
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Figure 3.3.4. Sortase-mediated ligation between AtV4IDR-B and TEV-AtV4IDR-A-HP. A) 15%
SDS- PAGE of SML monitored periodically for 48 hours. The reaction was performed alongside
controls at room temperature using 7m-srtA. B) Structure of the expected ligation product.
Residues within the PEST motif were mutated to create the LPXTG site with an extra glycine to
improve the reaction rate40. Wild-type amino acids are specified directly underneath the
substitution site.

This band is suspected to be the ligation product (LP) despite its molecular weight not matching
our expected calculated LP mass. This discrepancy is not unusual when performing SDS-PAGE
analysis. Indeed, 7m-srtA which is ~18 KDa and TEV-AtV4IDR-A-HP which is ~11.9 KDA both
appear as ~15-KDa bands. Furthermore, the absence of this 38-KDa band in the controls and at
the zero-hour time point suggests that the ligation product did indeed form. The presence of
other faint bands (e.g. at ~25KDa) correspond to impurities which can be observed as part of
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the AtV4IDR-B sample (Figure 3.3.3) and thus are unlikely to be the ligation product. LC-ESI-MS
analysis of the reaction mixture however failed to confirm the presence of any of the SML
components including the villin 4 LP likely due to very low signal-to-noise ratio. These results
are thus preliminary. More optimization is needed to synthesize then isolate the villin 4 IDR via
SML. The use of other sortase variants, different molar ratios to have excess of substrates in
order to minimize reversibility, as well as manipulation of temperature, buffer conditions, and
pH are currently under consideration to address this issue. Because problems with the SML
scheme was anticipated, efforts were invested in parallel to the above experiments to express
and purify the full-size linker as a single construct (AtV4IDR), bypassing the need for SML steps
(Figure 3.3.5). While this alternative prevents any possibility for segmental labeling of IDR
portions, it would still allow us to subject the IDR to F-actin binding assays. A one-liter
expression growth yielded 5 mL of AtV4IDR at 25 µM. By increasing the volume of bacterial
culture, enough AtV4IDR was produced for actin-binding and covalent modification studies
performed by fellow graduate students Jake Heins (thesis expected to be published in Spring
2023) and Derek McCaffrey (thesis expected to be published in Summer 2022), respectively.
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Figure 3.1.5. Synthesis of full-length villin 4 IDR (AtV4IDR). A) Structure of AtV4IDR including
twin strep and histidine tags for purification purposes. B) 15% SDS-PAGE of AtV4IDR. C) LC-ESIMS chromatogram of AtV4IDR

3.3.1 Future Works in Aim III:
Expression of AtV4IDR in minimal media (M9) for solution NMR spectroscopy studies is being
optimized. We intend to produce a uniformly 15N-labeled sample and collect corresponding 15NHSQC spectra to gain a better understanding of the IDR’s various conformational changes. A
new villin 4 IDR construct containing TEV-cleavable tags is being designed such that twin strep
and His6 could both be removed prior to any NMR analysis to not affect the resonances of
native IDR residues. The segmental labeling of the villin 4 linker may be revisited through the
use of different sortase variants, buffer conditions, or substrate ratios.
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Chapter IV: Conclusion
Large IDRs/IDPs play vital roles in cellular processes. Their dynamic nature allows them to
successfully perform various functions but this same characteristic represents one of the main
challenges when attempting to study their interactions and mode of operation. 2D
heteronuclear solution NMR spectroscopy has proven to be a unique tool with the capacity to
circumvent such difficulties, but the overlap of peaks observed in 15N-HSQC spectra collected
complicates the analysis process. Segmental labeling (SL), achieved through sortase-mediated
ligation reactions, aims to address the spectral convolution while maintaining the native amino
acid environment of the protein domain under investigation. Because SML has yet to be
performed in the context of IDR sequences, there is a great need to optimize the reaction
conditions under such unique circumstances. Indeed, our work indicates that in many cases, a
sortase-mediated ligation between two halves of authentic IDR segments is problematic likely
because of the identity of the amino acids surrounding the LPXTG site from the N- and Cterminal ends. Strategies to improve the ligation efficiency are currently under development in
our lab. The addition of glycine spacers, the use of different sortase variants or manipulation of
reaction parameters such as buffer composition, pH, and temperature are presently being
tested to arrive at a robust optimized protocol, universally applicable to all large IDRs. Two
model cytoskeletal regulator proteins were used as molecular test subjects to our SML
optimization studies, villin 4 (Arabidopsis thaliana) and dematin (Homo sapiens). In the case of
dematin, SML which occurred within its large IDR was successful in synthesizing the full-length
protein. This construct used contained the S381E mutation to mimic a phosphorylated
headpiece state. However, failure to isolate the ligation product from other reaction
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components in high enough yield currently prevents the collection of adequate 15N-HSQC data.
New dematin fragments designed to significantly differ in terms of their molecular weight from
the ligation product should allow for successful purification via SEC. A segmentally labeled
dematin sample should then be synthesized and analyzed via solution NMR spectroscopy to
determine whether the previously suspected intramolecular interaction occurs between
dematin’s IDR and its phosphorylated headpiece. If such binding is observed, identify of the
residues involved could be inferred from the location of 15N HSQC peaks. Using SML to
synthesize the full-length villin 4 IDR was not as successful as the dematin ligation reaction.
Fortunately a full-length villin 4 IDR was produced as one fragment. While segmental labeling
may not be possible for this construct, its ability to bind filamentous actin and undergo covalent
modifications was successfully demonstrated by fellow graduate students Jake Heins and Derek
McCaffrey under Dr. Sergey Smirnov’s supervision. Efforts to generate a uniformly isotopically
labeled AtV4IDR sample are underway to study the various conformational changes this IDR is
capable of adopting.
To ensure that the mutations introduced to create the LPXTG motif do not impact structure,
function, and interactions of the relevant protein constructs, 15N-HSQC of wild-type sequences
will eventually be collected and compared with the spectra obtained from our modified
sequences. Actin-binding assays shall also be conducted to ensure that dematin’s function is
preserved.
Because villin proteins are implicated in every developmental phase of root hair from the initial
bulge formation to hair elongation45, understanding villin 4’s mode of operation would lay the
foundations necessary to allow us to eventually control every step of such a process in order to
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engineer plants with longer, more abundant root hair with larger surface areas, capable of
absorbing more water and nutrients, ultimately producing crops at a higher yield which would
also be suited for high salinity and dry soil conditions. While our work on villin 4 aims to enrich
the agricultural field, our study of dematin may shed some light on the way through which it
interacts with filamentous actin in erythrocytes but also in prostate and breast tissues, bringing
us one step closer to understanding its cancer-suppressing properties1,7,8,38 as this protein
represents a potential alternative or complement to current cancer therapeutics.
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Appendix
Section 1: Amino Acid Sequences of Samples Discussed.
Proline-Rich C-terminus (ProC): DisProt ID DP00775
N-terminal ligation partner: protein substrate
Plasmid name: ProC_AroN_pET-24a(+)
Extinction coefficient: 1490 M-1 cm-1
MPSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSILSSGTSEN
LYFQGGGGGSGGGGSKEELHLPMTGGHHHHHH
C-terminal ligation partner: hexapeptide GPPPPPK(DNP)
ProC ligation product (LP)
MPSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSILSSGTSEN
LYFQGGGGGSGGGGSKEELHLPMTGPPPPPK(DNP)
Aromatic N-terminus (AroN): DisProt ID DP00088
N-terminal ligation partner: protein substrate
Plasmid name: AroN_AroN_pET-24a(+)
Extinction coefficient: 17990 M-1 cm-1
MPSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSILSSGTSEN
LYFQGGGGGSGGGGSWHIWWLPITGGHHHHHH
C-terminal ligation partner: hexapeptide: GFAGMIK(DNP)
AroN ligation product (LP):
MPSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSILSSGTSEN
LYFQGGGGGSGGGGSWHIWWLPITGFAGMIK(DNP)
Aromatic C-terminus (AroC): DisProt ID DP02488
N-terminal ligation partner: protein substrate
Plasmid name: AroC_AroN_pET-24a(+)
Extinction coefficient: 1490 M-1 cm-1
MPSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSILSSGTSEN
LYFQGGGGGSGGGGSNPEAPLPVTGGHHHHHH
C-terminal ligation partner: hexapeptide: GYYHWDK(DNP)
AroC ligation product (LP):
MPSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSILSSGTSEN
LYFQGGGGGSGGGGSNPEAPLPVTGYYHWDK(DNP)
Polar Charged N-terminus (PolN): DisProt ID DP00356
N-terminal ligation partner: protein substrate
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Plasmid name: PolN_AroN_pET-24a(+)
Extinction coefficient: 1490 M-1 cm-1
MPSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSILSSGTSEN
LYFQGGGGGSGGGGSDRIKELPETGGHHHHHH
C-terminal ligation partner: hexapeptide: GLGQNEK(DNP)
PolN ligation product (LP):
MPSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSILSSGTSEN
LYFQGGGGGSGGGGSDRIKELPETGLGQNEK(DNP)
PolN system Controls:
PolN-5Gly ligation product (LP)
MPSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSILSSGTSEN
LYFQGGGGGSGGGGSDRIKELPETGGGGGK(DNP)
5GlyN-PolN ligation product (LP)
MPSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSILSSGTSEN
LYFQGGGGGSGGGGSGGGGGLPETGLGQNEK(DNP)
Glycine Control (GlyC)
N-terminal glycine control: protein substrate (also used as N-terminal ligation partner for 5GlyNPolN LP)
Plasmid name: GGGGG_AroN_pET-24a(+)
Extinction coefficient: 1490 M-1 cm-1
MPSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSILSSGTSEN
LYFQGGGGGSGGGGSGGGGGLPETGGHHHHHH
C-terminal glycine control: pentapeptide (also used as C-terminal ligation partner for PolN-5Gly
LP) GGGGGK(DNP)
MPSVQEVEKLLHVLDRNGDGKVSAEELKAFADDSKCPLDSNKIKAFIKEHDKNKDGKLDLKELVSILSSGTSEN
LYFQGGGGGSGGGGSGGGGGLPETGGGGGK(DNP)
Dematin (HP)
Plasmid name: Dem_SML301-305_Cterm_pET-24a(+)
Extinction coefficient: 9970 M-1 cm-1
MHHHHHHENLYFQGFSPSGSETGSPGLQIYPYEMLVVTNKGRTKLPPGVDRMRLERHLSAEDFSRVFAMSP
EEFGKLALWKRNELKKKASLF
Dematin TEV-HP
Extinction coefficient: 8480 M-1 cm-1
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GFSPSGSETGSPGLQIYPYEMLVVTNKGRTKLPPGVDRMRLERHLSAEDFSRVFAMSPEEFGKLALWKRNEL
KKKASLF
Dematin (P) HP
Plasmid name: Dem_SML301-305_Cterm_Phos_pET-24a(+)
Extinction coefficient: 9970 M-1 cm-1
MHHHHHHENLYFQGFSPSGSETGSPGLQIYPYEMLVVTNKGRTKLPPGVDRMRLERHLSAEDFSRVFAMSP
EEFGKLALWKRNELKKKAELF
Dematin (P) TEV-HP
Extinction coefficient: 8480 M-1 cm-1
GFSPSGSETGSPGLQIYPYEMLVVTNKGRTKLPPGVDRMRLERHLSAEDFSRVFAMSPEEFGKLALWKRNEL
KKKAELF
Dematin IDR
Plasmid name: Strep-IDR-SML301-305-His6_pET-24a(+)
Extinction coefficient: 39420 M-1 cm-1
MWSHPQFEKGSGGASWSHPQFEKGGGENLYFQSERLQKQPLTSPGSVSPSRDSSVPGSPSSIVAKMDNQV
LGYKDLAAIPKDKAILDIERPDLMIYEPHFTYSLLEHVELPRQRERSLSPKAAAGGGAGKVWADSRSPGIISQAS
APRTTGTPRTSLPHFHHPETSRPDSNIYKKPPIYKQRESVGGSPQTKHLIEDLIIESSKFPAAQPPDPNQPAKIET
DYWPCPPSLAVVETEWRKRKASRRGAEEEEEEEDDDSGEEMKALRERQREELSKVTSNLGKMILKEEMEKSL
PIRRKTRSLPDRTPFHTSLHQGTSKSSSLPAYGRTTLSRLPSTGGHHHHHH
Dematin (P) LP (utilizing the LPSTG site at position 301-305)
Extinction coefficient: 47900 M-1 cm-1
MWSHPQFEKGSGGASWSHPQFEKGGGENLYFQSERLQKQPLTSPGSVSPSRDSSVPGSPSSIVAKMDNQV
LGYKDLAAIPKDKAILDIERPDLMIYEPHFTYSLLEHVELPRQRERSLSPKAAAGGGAGKVWADSRSPGIISQAS
APRTTGTPRTSLPHFHHPETSRPDSNIYKKPPIYKQRESVGGSPQTKHLIEDLIIESSKFPAAQPPDPNQPAKIET
DYWPCPPSLAVVETEWRKRKASRRGAEEEEEEEDDDSGEEMKALRERQREELSKVTSNLGKMILKEEMEKSL
PIRRKTRSLPDRTPFHTSLHQGTSKSSSLPAYGRTTLSRLPSTGFSPSGSETGSPGLQIYPYEMLVVTNKGRTKLP
PGVDRMRLERHLSAEDFSRVFAMSPEEFGKLALWKRNELKKKAELF
Dematin C-IDR-HP
Plasmid name: Dem_HP_nophos_156-160_ pET-24a(+)
Extinction coefficient: 23950 M-1 cm-1
MHHHHHHHHENLYFQGHLIEDLIIESSKFPAAQPPDPNQPAKIETDYWPCPPSLAVVETEWRKRKASRRGAE
EEEEEEDDDSGEEMKALRERQREELSKVTSNLGKMILKEEMEKSLPIRRKTRSLPDRTPFHTSLHQGTSKSSSLP
AYGRTTLSRLQSTEFSPSGSETGSPGLQIYPYEMLVVTNKGRTKLPPGVDRMRLERHLSAEDFSRVFAMSPEE
FGKLALWKRNELKKKASLF
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Dematin N-IDR
Plasmid name: DualStrep_IDR-156-160_ pET-24a(+)
Extinction coefficient: 25440 M-1 cm-1
MWSHPQFEKGSGGASWSHPQFEKGGGENLYFQGERLQKQPLTSPGSVSPSRDSSVPGSPSSIVAKMDNQV
LGYKDLAAIPKDKAILDIERPDLMIYEPHFTYSLLEHVELPRSRERSLSPKAAAGGGAGKVWADSRSPGIISQAS
APRTTGTPRTSLPHFHHPETSRPDSNIYKKPPIYKQRESVGGLPQTGGHHHHHHHH
Dematin LP (utilizing LPQTG site at position 156-160)
Extinction coefficient: 47900 M-1 cm-1
MWSHPQFEKGSGGASWSHPQFEKGGG ENLYFQGERLQKQPLTSPGSVSPSRDSSVPGSPSSIVAKMDNQ
VLGYKDLAAIPKDKAILDIERPDLMIYEPHFTYSLLEHVELPRSRERSLSPKAAAGGGAGKVWADSRSPGIISQA
SAPRTTGTPRTSLPHFHHPETSRPDSNIYKKPPIYKQRESVGGLPQTGHLIEDLIIESSKFPAAQPPDPNQPAKIE
TDYWPCPPSLAVVETEWRKRKASRRGAEEEEEEEDDDSGEEMKALRERQREELSKVTSNLGKMILKEEMEKS
LPIRRKTRSLPDRTPFHTSLHQGTSKSSSLPAYGRTTLSRLQSTEFSPSGSETGSPGLQIYPYEMLVVTNKGRTKL
PPGVDRMRLERHLSAEDFSRVFAMSPEEFGKLALWKRNELKKKASLF
AtV4IDR
Plasmid name: sABh_pET-24a(+)
Extinction coefficient: 13980 M-1 cm-1
MWSHPQFEKGSGGASWSHPQFEKGGGDSSKSAMHGNSFQRKLKIVKNGGTPVADKPKRRTPASYGGR
ASVPDKSQQRSRSMSFSPDRVRVRGRSPAFNALAATFESQNARNLSTPPPVVRKLYPRSVTPDSSKFAPAPKS
SAIASRSALFEKIPPQEPSIPKPVKASPKTPEAAAGGGAGKEQEEKKENDKEEGSMSSRIESLTIQEDAKEGVED
EEDGGHHHHHHHH
AtV4IDR-A-HP
Plasmid name: VLN4_B_ pET-24a(+)
Extinction coefficient: 22460 M-1 cm-1
MWSHPQFEKGSGGASWSHPQFEKGGGHHHHHHHHENLYFQGGKEQEEKKENDKEEGSMSSRIESLTIQE
DAKEGVEDEEDLPAHPYDRLKTTSTDPVSDIDVTRREAYLSSEEFKEKFGMTKEAFYKLPKWKQNKFKMAVQ
LF
AtV4IDR-B
Plasmid name: VLN4_A_ pET-24a(+)
Extinction coefficient: 15470 M-1 cm-1
MWSHPQFEKGSGGASWSHPQFEKGGGENLYFQSSKSAMHGNSFQRKLKIVKNGGTPVADKPKRRTPASY
GGRASVPDKSQQRSRSMSFSPDRVRVRGRSPAFNALAATFESQNARNLSTPPPVVRKLYPRSVTPDSSKFAP
APKSSAIASRSALFEKIPPQEPSIPKPVKASPKTPESPLPETGGHHHHHHHH
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WT-SrtA
Extinction coefficient: 14440 M-1 cm-1
MRGSSHHHHHHSSGLVPRGSHMQAKPQIPKDKSKVAGYIEIPDADIKEPVYPGPATPEQLNRGVSFAEENES
LDDQNISIAGHTFIDRPNYQFTNLKAAKKGSMVYFKVGNETRKYKMTSIRDVKPTDVGVLDEQKGKDKQLTLI
TCDDYNEKTGVWEKRKIFVATEVK
7m-SrtA
Extinction coefficient: 14440 M-1 cm-1
MQAKPQIPKDKSKVAGYIEIPDADIKEPVYPGPATREQLNRGVSFAKENQSLDDQNISIAGHTFI
DRPNYQFTNLKAAKKGSMVYFKVGNETRKYKMTSIRNVKPTAVEVLDEQKGKDKQLTLITCDD
YNEETGVWETRKIFVATEVKLEHHHHHH
TEV-Protease
Extinction coefficient: 40005 M-1 cm-1
GHIVWPDYANILKEVFGGARMACVTSAHMAGANGSILKKAEETSRATMHKPVIFGEDYVTEADL
PYTPLHLEVNAEMERMYYLGRRALTHGKRRKVSVNNKRNRRRKVAKTYVGRDSIVEKIVVPHT
ERKVDTTTAVKDTCNEVSTQLVHNSMPKRKKQKNFLPATSLSNVYAQTWSIVRKRHMQVEIISK
KSVRAKVKRFEGSVQLFASVRHMYGERKRVDLRIDNWQQKTLLDLAKRFKNERVDQSKLTFG
SSGLVLRQGSYAPAHWYRHGMFIVRGRSDGMLVDARAKVTFAVCYSMTHYHHHHHH
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Section 2: SML Reaction Schemes.

Appendix Figure 2.1. Aim II SML Scheme 1. SML to make full-length dematin (P) LP utilizing
LPXTG site at positions 301-305.

Appendix Figure 2.2. Aim II SML Scheme 2. SML to make full-length dematin LP utilizing LPXTG
site at positions 156-160. The reaction has yet to be run.
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Appendix Figure 2.3. Aim II SML Control Reaction. The LPXTG site is at positions 301-305. SML
was run for 4 hours under the same conditions described in the Materials and Methods section
2.8b. Control reactions are missing one different SML component each, indicated above
corresponding lanes. Image also found in Erin Rosenkranz’s thesis39 (OCLC# 1277514139).

Appendix Figure 2.4. Aim III SML Scheme. Mutated residues within predicted PEST motif are
underlined. Wild-type amino acids are shown directly underneath the substitution site.
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